Basepair

Basepair

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $5.6M

Overview

Basepair, founded in 2015 and headquartered in New York, has developed a distinctive cloud bioinformatics platform that addresses critical pain points in genomic data analysis: data movement, cost, and accessibility. Its key differentiator is the ability to provision its SaaS solution directly within a client's existing AWS cloud environment, allowing organizations to maintain full data governance and leverage prior infrastructure investments. The company targets a broad market from academic researchers to diagnostic developers, offering flexible pricing and tools that democratize analysis for both bench scientists and bioinformaticians. Strategic partnerships with AWS, NVIDIA, and global distributors underscore its growth trajectory in the federated genomics analysis space.

Genetics & GenomicsAI / Machine LearningDiagnostics

Technology Platform

Federated, cloud-native SaaS platform for NGS data analysis that deploys within a customer's own AWS account, featuring a GUI/CLI interface, pre-built & custom workflows, interactive visualization, and white-labeling capabilities.

Funding History

3
Total raised:$5.6M
Seed$5M
Grant$348K
Grant$299K

Opportunities

The rapid growth of clinical NGS and regulated diagnostics creates demand for secure, branded analysis platforms, a core strength of Basepair's white-label offering.
Global expansion through distribution agreements in regions like Japan, Australia, and Southeast Asia opens new revenue streams in emerging genomics markets.
The industry-wide shift to cloud infrastructure and the need to control costs present a persistent tailwind for its value proposition of reducing data movement and optimizing cloud spend.

Risk Factors

Deep reliance on AWS creates platform dependency and potential vulnerability if competitors offer compelling multi-cloud solutions.
The market is highly competitive, with pressure from both sophisticated open-source frameworks and well-funded commercial rivals.
Adoption in the critical clinical and pharma sectors can be slow due to long validation cycles and inherent conservatism regarding new software platforms.

Competitive Landscape

Basepair competes in a fragmented market including open-source workflow managers (Nextflow, Snakemake), legacy informatics suites from sequencing giants (Illumina DRAGEN, Thermo Fisher), and other commercial cloud bioinformatics platforms (DNAnexus, Seven Bridges, Partek Flow). Its primary differentiation is the federated deployment model that prioritizes data sovereignty and cost control, setting it apart from vendors who require data upload to their managed clouds.